Progress update #1: Existing knowledge and the research gap

Previous post:  proposed that dual inhibition of Fe–S biogenesis and RNR could outperform either alone.

Objective:  To establish what is already known about each target ,whether they are individually validated and essential across bacteria, fungi, parasites, viruses, and cancer & where the knowledge stops.

Work completed:  I reviewed the literature on both pathways and on the agents that act on them.

Evidence:

• Cysteine desulfurase chemistry is deeply conserved: SufS (bacteria), IscS (viruses), and NFS1 (eukaryotes) all catalyze the PLP-dependent desulfurization of L-cysteine to a catalytic persulfide which is the committed step of cluster assembly.

• RNR. It catalyses the committed step of dNTP synthesis. Its R2 subunit needs a diferric-tyrosyl radical that thiosemicarbazones can quench; Triapine reached Phase II/III but acts on RNR alone.

• Existing agents. Hydroxyurea, Triapine, Ti(HBED), Ti(Deferasirox), compound '882, EAC and compound 53 each address at most one system.

What changed:  The project now has a defined gap, not just an idea. The field possesses two validated, mechanistically orthogonal, iron-dependent targets and a mature modality toolbox, but no agent that converges them. Our project occupies exactly that empty cell of the design space.

Current interpretation:  Three questions remain open.

1. Does combining the two targets produce true synergy, or only additive effects?

2. Can a single agent deliver both inhibitors while preserving the mechanistic burden that confers resistance suppression and whether host selectivity survives  the coupling?

3. Is there a binding site on the cysteine desulfurase family that is conserved enough to support a drug modality approach which has not been attempted?

Next step: The evidence suggests that the main uncertainty is no longer biological plausibility but testability: can dual inhibition be demonstrated quantitatively and can a rational testing framework be defined before any experimental capital is committed? The next post will define that validation plan: the models, datasets, controls, variables, measurements, and success criteria.